Cell & Gene Therapy

market volatility volatile wall street chart
Biotech

Volatile day for CAR-T biotechs after FDA reveals safety review

CAR-T therapy biotechs had a tough day at the market after the FDA announced a probe into secondary cancers that can occur after the treatments.
Annalee Armstrong Nov 28, 2023 4:35pm
Rendering of an immune cell

'Special' CAR-T target works in solid tumors, but limits remain

Nov 28, 2023 9:00am
Graphic image of someone cutting off a row of stick figures symbolizing employees

CRISPR Therapeutics laid off staff a week after positive AdComm

Nov 22, 2023 1:36pm
graphic image of the gene sequencing process

Flagship launches first UK biotech Quotient Therapeutics

Nov 21, 2023 6:00am
question unanswered wonder ask

Astellas finds underlying liver issues in gene therapy deaths

Nov 16, 2023 7:12am
market busy fresh fruit buy crowd

Gilead hands Arcellx $285M to expand BCMA cell therapy deal

Nov 15, 2023 10:00am
More News

Selecta fuses with Cartesian in reverse merger

Nov 13, 2023 10:30am

Verve shows base editing works in humans—and sees stock sink

Nov 13, 2023 8:43am

Vor Bio's dual stem cell, ADC shows consistent engraftment

Nov 9, 2023 4:10pm

Trio of biotechs toss programs to discard pile

Nov 9, 2023 11:23am